Editorial
Published on 13 Mar 2023
Editorial: Hallmark of cancer: Evasion of growth suppressors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1170115
- 2,626 views
- 2 citations
Type at least 3 characters
2,923 articles
Articles
Original Research
Published on 13 Mar 2023
An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1002792
- 4,799 views
- 3 citations
Original Research
Published on 13 Mar 2023
Epiregulin expression and secretion is increased in castration-resistant prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1107021
- 2,248 views
- 1 citation
Review
Published on 13 Mar 2023
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1013359
- 5,506 views
- 7 citations
Review
Published on 10 Mar 2023
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1132319
- 20,595 views
- 33 citations
Methods
Published on 10 Mar 2023
ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.920698
- 2,518 views
Original Research
Published on 10 Mar 2023
Non-canonical Wnt/Ca2+ signaling is essential to promote self-renewal and proliferation in colon cancer stem cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1121787
- 6,004 views
- 8 citations
Editorial
Published on 10 Mar 2023
Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1164399
- 1,295 views
Review
Published on 09 Mar 2023
Targeted therapies for the treatment of soft tissue sarcoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1122508
- 7,778 views
- 10 citations
Original Research
Published on 09 Mar 2023
The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1111094
- 1,713 views
- 4 citations
Brief Research Report
Published on 09 Mar 2023
FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1096499
- 1,486 views
Original Research
Published on 09 Mar 2023
Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1097667
- 2,748 views
- 2 citations
Review
Published on 09 Mar 2023
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1063636
- 5,964 views
- 32 citations
Editorial
Published on 09 Mar 2023
Editorial: CRISPR advancement in cancer research and future perspectives
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1173527
- 938 views
- 1 citation
Original Research
Published on 09 Mar 2023
UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1088475
- 2,905 views
- 7 citations
Correction
Published on 08 Mar 2023
Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1162375
- 1,259 views
- 1 citation